CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,450,000 | -11.6% | 3,000,000 | 0.0% | 2.85% | -13.6% |
| Q4 2022 | $78,600,000 | +33.3% | 3,000,000 | 0.0% | 3.30% | +22.2% |
| Q3 2022 | $58,980,000 | -1.7% | 3,000,000 | -12.5% | 2.70% | -31.5% |
| Q2 2022 | $59,993,000 | +22.2% | 3,430,110 | +14.3% | 3.94% | +25.3% |
| Q1 2022 | $49,080,000 | +24.3% | 3,000,000 | +23.9% | 3.15% | +12.9% |
| Q4 2021 | $39,478,000 | – | 2,420,502 | – | 2.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |